Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same […]
from LinkeWire http://bit.ly/2P1dPgV
from LinkeWire http://bit.ly/2P1dPgV
Comments
Post a Comment